WashU Med infectious diseases specialist Steven J. Lawrence, MD, looks back and forward, detailing some of the frustrations, surprises and successes of the past two years as we begin a third year of life in a pandemic.
Eligible employees may receive the second booster dose at two convenient locations on the Medical Campus.
If a cluster of COVID-19 infections is identified in a non-clinical area where masking is not currently required but strongly encouraged, all employees in that work area or team will be required to mask until the cluster is resolved.
In response to a steady rise in case numbers, WashU Med strongly recommends masking in all indoor, non-private spaces on the Medical Campus.
WashU Med strongly encourages masking in non-clinical areas, where to get a second booster.
New guidance for employees who test positive, monoclonal antibody/Evusheld therapies transition to normal operations, additional booster eligibility, Podcast: Long-COVID
Ziyad Al-Aly, MD, and Simon Haroutonian, PhD, discuss their findings that suggest COVID-19 infection raises the risk for kidney problems, heart issues, diabetes, peripheral neuropathy and psychiatric disorders, such as depression and anxiety.
The new guidance is effective as of April 11, 2022.
Learn more about how the administration of mAb and Evusheld therapies will be impacted.
Boosters are available at the BJC Institute of Health and other locations.